Chronic myeloid leukemia with a rare fusion transcript, b2a3 (e13a3) BCR–ABL1: A report of four cases from India

Chronic myeloid leukemia with a rare fusion transcript, b2a3 (e13a3) BCR–ABL1: A report of four cases from India

Bibliographic Details
Main Authors:	Sudha Sazawal, Sunita Chhikara, Kanwaljeet Singh, Rekha Chaubey, Manoranjan Mahapatra, Tulika Seth, Renu Saxena
Format:	Article
Language:	English
Published:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2019-01-01
Series:	South Asian Journal of Cancer
Online Access:	http://journal.sajc.org/article.asp?issn=2278-330X;year=2019;volume=8;issue=2;spage=107;epage=123;aulast=Sazawal

Similar Items

Distribution of common BCR-ABL fusion transcripts and their impact on treatment response in Imatinib treated CML patients: A study from India
by: Sudha Sazawal, et al.
Published: (2019-01-01)

Comparative analysis of the Sokal, Euro and European Treatment and Outcome Study score in prognostication of Indian chronic myeloid leukemia-chronic phase patients on imatinib
by: Sunita Chhikara, et al.
Published: (2018-01-01)

Influence of JAK2V617F allele burden on clinical phenotype of polycythemia vera patients: A study from India
by: Sudha Sazawal, et al.
Published: (2019-01-01)

NPM1 and FLT3 mutations in acute myeloid leukemia with normal karyotype: Indian perspective
by: Sudha Sazawal, et al.
Published: (2017-01-01)

Reversal of Glanzmann thrombasthenia platelet phenotype after imatinib treatment in a pediatric chronic myeloid leukemia patient
by: Richa Chauhan, et al.
Published: (2018-02-01)

Association of JAK2V617F mutation with thrombosis in Indian patients with Philadelphia negative chronic myeloproliferative neoplasms
by: Kanwaljeet Singh, et al.
Published: (2018-01-01)

Polycythemia vera: Correlation of JAK2V617F mutation with clinicohematologic characteristics. A single centre experience.
by: Deepti Mutreja, et al.
Published: (2014-08-01)

BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia
by: Federica Loscocco, et al.
Published: (2019-09-01)

BCR-ABL promotes PTEN downregulation in chronic myeloid leukemia.
by: Cristina Panuzzo, et al.
Published: (2014-01-01)

Cytogenetics' impact on the prognosis of acute myeloid leukemia
by: Monika Gupta, et al.
Published: (2019-04-01)

Characteristics of BCR–ABL gene variants in patients of chronic myeloid leukemia
by: Amin Huma, et al.
Published: (2021-06-01)

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
by: Diletta Fontana, et al.
Published: (2021-11-01)

Successful treatment with ABL tyrosine kinase inhibitor for patients with acute myeloid leukemia with BCR-ABL1
by: Asako Takeuchi, et al.
Published: (2021-01-01)

BCR-ABL gene amplification in patients with chronic myeloid leukemia and imatinib resistance
by: S. I. Kutzev, et al.
Published: (2022-11-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: M Yaghmaie, et al.
Published: (2005-09-01)

Frequency of BCR-ABL Fusion Transcript in Iranian Patients with Chronic Myeloid Leukemia
by: Yaghmaie M., et al.
Published: (2005-09-01)

Fusion gene bcr-abl: From etiopathogenesis to the management of chronic myeloid leukemia
by: Tri Agusti Sholikah
Published: (2017-04-01)

Prognostic Significance of Transcript-Type BCR‐ABL1 in Chronic Myeloid Leukemia
by: matteo molica, et al.
Published: (2020-08-01)

Philadelphia Chromosome-positive Acute Myeloid Leukemia With e1a3 BCR-ABL1 Fusion Transcript
by: Julia W. Sheets, et al.
Published: (2020-12-01)

Transcripto BCR-ABL atípico en un paciente con leucemia mieloide crónica Atypical BCR-ABL transcript in a patient with chronic myeloid leukemia
by: Ana María Amor Vigil, et al.
Published: (2011-09-01)

Trisomy Chromosome 6 as a Sole Cytogenetic Abnormality in Acute Myeloid Leukemia
by: Monika Gupta, et al.
Published: (2015-02-01)

Frequencies of BCR::ABL1 Transcripts in Patients with Chronic Myeloid Leukemia: A Meta-Analysis
by: Pablo Romero-Morelos, et al.
Published: (2024-02-01)

Nickel pyrithione induces apoptosis in chronic myeloid leukemia cells resistant to imatinib via both Bcr/Abl-dependent and Bcr/Abl-independent mechanisms
by: Xiaoying Lan, et al.
Published: (2016-11-01)

Spectrum of BCR-ABL mutations in Azerbaijanian imatinib-resistant patients with chronic myeloid leukemia
by: Aypara Hasanova, et al.
Published: (2023-12-01)

Allogeneic hematopoietic cell transplantation for acute myeloid leukemia with BCR::ABL1 fusion
by: Shohei Mizuno, et al.
Published: (2024-04-01)

Initial Rate of BCR: : ABL1 Decline for Response Prediction in Chronic Myeloid Leukemia
by: Susan Branford
Published: (2022-08-01)

Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts
by: Brittany M. Smith, et al.
Published: (2021-11-01)

Importance of adherence to BCR-ABL tyrosine-kinase inhibitors in the treatment of chronic myeloid leukemia
by: Maria Helena de Almeida, et al.
Published: (2014-01-01)

Detection of p190BCR-ABL AND p210BCR-ABL fusion transcripts in patients with chronic myeloid leukemia (CML) using qualitative RT-PCR
by: Aya Bonilla, Carlos Alberto, et al.
Published: (2014-10-01)

A Study on BCR-ABL Kinase Domain Mutations in Chronic Myeloid Leukemia from Western India
by: Pankaj Gadhia, et al.
Published: (2021-10-01)

A review on characterization of BCR – ABL transcript variants for molecular monitoring of chronic myeloid leukemia phenotypes
by: Benyam Zenebe, et al.
Published: (2023-12-01)

Atypical chronic myeloid leukemia BCR-ABL 1 negative: A case report and literature review
by: Jihane Belkhair, et al.
Published: (2019-01-01)

Detection of BCR-ABL T315i mutation in imatinib resistant chronic myeloid leukemia patients
by: Mardziah M,, et al.
Published: (2019)

Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia
by: Christian Volz, et al.
Published: (2023-10-01)

The Effect of BCR-ABL Specific Tyrosine Kinase Inhibitors on the Thioredoxin System in Chronic Myeloid Leukemia
by: Erin Clapper, et al.
Published: (2021-05-01)

BCR-ABL EXON 7 DELETION IN CHRONIC MYELOID LEUKEMIA: CHALLENGES IN POINT MUTATIONS ANALYSIS
by: JB Costa, et al.
Published: (2023-10-01)

Frequency of BCR-ABL 1 Fusion Transcripts Variants in Chronic Myeloid Leukemia Algerian patients
by: Mourad NACHI, et al.
Published: (2020-06-01)

Simvastatin enhances the efficacy of Bcr-Abl tyrosine kinase inhibitor nilotinib in chronic myeloid leukemia.
by: Koh, Yanqing.
Published: (2011)

Frequency of BCR-ABL 1 Fusion Transcripts Variants in Chronic Myeloid Leukemia Algerian patients
by: Mourad NACHI, et al.
Published: (2020-06-01)

Frecuencia de los transcriptos BCR-ABL en pacientes cubanos con leucemia mieloide crónica Frequency of BCR-ABL transcripts in Cuban patients with chronic myeloid leukemia
by: Ana María Amor-Vigil, et al.
Published: (2012-12-01)